<DOC>
	<DOC>NCT00759395</DOC>
	<brief_summary>This study will determine if a highly selective enkephalinergic receptor modulator is effective in the treatment of anxious major depressive disorder.</brief_summary>
	<brief_title>Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Provision of informed consent prior to any study specific procedures Diagnosis of major depressive disorder without psychotic features (MDD) A history of substance or alcohol abuse within the past 6 months or dependence within 1 year of enrollment as defined by DSMIV criteria. Women that are pregnant or lactating History of pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Anxious Major Depressive Disorder</keyword>
</DOC>